Company type | Private |
---|---|
Industry | Clinical and applied markets |
Founded | 2014 |
Founders | Sasan Amini, Ramin Khaksar |
Headquarters | , |
Area served | Global |
Key people | Sasan Amini, CEO and Co-founder; Ramin Khaksar, CSO, COO, and Co-founder |
Products | Fully automated genomics testing |
Number of employees | 50+ |
Website |
www |
Clear Labs, Inc. is a private genomics testing company headquartered in San Carlos, California, United States. It offers a fully automated, next-generation sequencing (NGS) platform for turnkey diagnostics, including SARS-CoV-2 genomic characterization and detection of foodborne pathogens such as listeria and salmonella. [1] It can also verify a food's ingredients, its GMO status, or conduct other tests. [2]
Clear Labs was co-founded by Sasan Amini in 2014, [3] who left his job at a genomics company to start Clear Labs. [4] The company acquired $6.5 million in series A financing in September 2015. [3] In December 2016, the company closed a $16 million Series B funding round. [5] This was followed by another $21 million round in October 2018. [6]
Clear Labs was granted an Emergency Use Authorization (EUA) from the US FDA in September 2020 for its SARS-CoV-2 descriptive diagnostic test. [7] Clear Labs launched in January 2021 a groundbreaking solution for whole genome sequencing surveillance of SARS-CoV-2 and its mutations. [8] Clear Labs announced in March 2021 that the company had reached a critical milestone of over 50% public health laboratory penetration with its whole genome sequencing SARS-CoV-2 product, [9] [10] including laboratories such as Nebraska, [11] [12] [13] Nevada, [14] [15] New York, [16] California [17] and Kansas, [18] among others. Clear Labs Raised a $60M Series C round led by Morgan Stanley and T. Rowe Price in May 2021. [19]
Clear Labs has also received governmental and professional certification for its food safety next generation sequencing platform, including from the International AOAC [20] in December 2019 and the National Poultry Improvement Plan in October 2021. [21]
Company type | Private |
---|---|
Industry | Clinical and applied markets |
Founded | 2014 |
Founders | Sasan Amini, Ramin Khaksar |
Headquarters | , |
Area served | Global |
Key people | Sasan Amini, CEO and Co-founder; Ramin Khaksar, CSO, COO, and Co-founder |
Products | Fully automated genomics testing |
Number of employees | 50+ |
Website |
www |
Clear Labs, Inc. is a private genomics testing company headquartered in San Carlos, California, United States. It offers a fully automated, next-generation sequencing (NGS) platform for turnkey diagnostics, including SARS-CoV-2 genomic characterization and detection of foodborne pathogens such as listeria and salmonella. [1] It can also verify a food's ingredients, its GMO status, or conduct other tests. [2]
Clear Labs was co-founded by Sasan Amini in 2014, [3] who left his job at a genomics company to start Clear Labs. [4] The company acquired $6.5 million in series A financing in September 2015. [3] In December 2016, the company closed a $16 million Series B funding round. [5] This was followed by another $21 million round in October 2018. [6]
Clear Labs was granted an Emergency Use Authorization (EUA) from the US FDA in September 2020 for its SARS-CoV-2 descriptive diagnostic test. [7] Clear Labs launched in January 2021 a groundbreaking solution for whole genome sequencing surveillance of SARS-CoV-2 and its mutations. [8] Clear Labs announced in March 2021 that the company had reached a critical milestone of over 50% public health laboratory penetration with its whole genome sequencing SARS-CoV-2 product, [9] [10] including laboratories such as Nebraska, [11] [12] [13] Nevada, [14] [15] New York, [16] California [17] and Kansas, [18] among others. Clear Labs Raised a $60M Series C round led by Morgan Stanley and T. Rowe Price in May 2021. [19]
Clear Labs has also received governmental and professional certification for its food safety next generation sequencing platform, including from the International AOAC [20] in December 2019 and the National Poultry Improvement Plan in October 2021. [21]